Influence of Sex Hormones on Cancer Progression

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

(2005) · The Lancet · doi:10.1016/s0140-6736(05)66544-0 · Cited by 7,530 · see citing works

The Epigenomics of Cancer

Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515 · see citing works

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613 · see citing works

Cancer Statistics, 2001

Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281 · see citing works

Molecular determinants of resistance to antiandrogen therapy

Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · see citing works

Mechanisms of estrogen action.

Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., & Gustafsson, J.-Å. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1535 · Cited by 2,059 · see citing works

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

Baum, M., Budzar, A. U., Cuzick, J. M., Forbes, J., Houghton, J., Klijn, J. G. M., & Sahmoud, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09088-8 · Cited by 1,958 · see citing works

Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies

The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.606 · Cited by 1,793 · see citing works

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759 · see citing works

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer

Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,240 · see citing works

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191 · see citing works

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase

Craft, N., Shostak, Y., Carey, M., & Sawyers, C. L. (1999) · Nature Medicine · doi:10.1038/6495 · Cited by 980 · see citing works

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903 · see citing works

Colorectal Cancer: Molecules and Populations

Potter, J. D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.916 · Cited by 870 · see citing works

Androgen Levels Increase by Intratumoral <i>De novo</i> Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747 · see citing works

Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

Ellis, M. J., Tao, Y., Luo, J. R., A’Hern, R., Evans, D. B., Bhatnagar, A. S., Ross, H. A. C., von Kameke, A., Miller, W. R., Smith, I., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn309 · Cited by 654 · see citing works

Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-Hydroxytamoxifen

Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0009 · Cited by 645 · see citing works

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

Attard, G., Reid, A. H. M., A'Hern, R., Parker, C., Oommen, N. B., Folkerd, E., Messiou, C., Molife, L. R., Maier, G., Thompson, E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0642 · Cited by 605 · see citing works

Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Geisler, J., Haynes, B., Anker, G., Dowsett, M., & Lønning, P. E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.751 · Cited by 604 · see citing works

Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)

Small, E. J., Halabi, S., Dawson, N. A., Stadler, W. M., Rini, B. I., Picus, J., Gable, P. S., Torti, F. M., Kaplan, E. B., & Vogelzang, N. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.037 · Cited by 503 · see citing works

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

Thigpen, J. T., Brady, M. F., Alvarez, R. D., ADELSON, M. D., Homesley, H. D., Manetta, A., Soper, J. T., & Given, F. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1736 · Cited by 483 · see citing works

Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.

Goff, P. L., Montano, M. M., Schodin, D. J., & Katzenellenbogen, B. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41801-1 · Cited by 452 · see citing works

Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression

Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 424 · see citing works

Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-Blind, Randomized Trial

Howell, A., Robertson, J. F. R., Abram, P., Lichinitser, M., Elledge, R. M., Bajetta, E., Watanabe, T., Morris, C. Q., Webster, A., Dimery, I. W., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.112 · Cited by 422 · see citing works

Selective estrogen receptor modulators: structure, function, and clinical use.

Osborne, C. K., Zhao, H., & Fuqua, S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3172 · Cited by 382 · see citing works

Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women

Dunning, A. M., Dowsett, M., Healey, C. S., Tee, L. J., Luben, R., Folkerd, E. J., Novik, K. L., Kelemen, L., Ogata, S., Pharoah, P. D. P., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh167 · Cited by 346 · see citing works

The role of estrogens and estrogen receptors in normal prostate growth and disease

Prins, G. S., & Korach, K. S. (2007) · Steroids · doi:10.1016/j.steroids.2007.10.013 · Cited by 331 · see citing works

The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response

Castellano, L., Giamas, G., Jacob, J., Coombes, R. C., Lucchesi, W., Thiruchelvam, P. T. R., Barton, G. R., Jiao, L. R., Wait, R., Waxman, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906947106 · Cited by 329 · see citing works

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

Chlebowski, R. T., Schwartz, A. G., Wakelee, H. A., Anderson, G. L., Stefanick, M. L., Manson, J. E., Rodabough, R. J., Chien, J. W., Wactawski‐Wende, J., Gass, M. L. S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61526-9 · Cited by 322 · see citing works

Molecular mechanisms of selective estrogen receptor modulator (SERM) action.

Dutertre, M., & Smith, C. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38923-2 · Cited by 320 · see citing works

Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen Deprivation

Martin, L., Farmer, I., Johnston, S. R. D., Ali, S., Marshall, C., & Dowsett, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305226200 · Cited by 295 · see citing works

Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer

Gershanovich, M., Chaudri, H. A., Campos, D., Lurie, H., Bonaventura, A., Jeffrey, M., Buzzi, F., Bodrogi, I., Ludwig, H., Reichardt, P., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008226721932 · Cited by 255 · see citing works

Gender Disparities in Metastatic Colorectal Cancer Survival

Hendifar, A. E., Yang, D., Lenz, F., Lurje, G., Pohl, A., Lenz, C., Ning, Y., Zhang, W., & Lenz, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0877 · Cited by 206 · see citing works

Tumor Repressive Functions of Estrogen Receptor β in SW480 Colon Cancer Cells

Hartman, J., Edvardsson, K., Lindberg, K., Zhao, C., Williams, C., Ström, A., & Gustafsson, J.-Α. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0506 · Cited by 201 · see citing works

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Rose, P. G., Filiaci, V. L., Le, L. V., Bell, J., Walker, J. L., & Lee, R. B. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5865 · Cited by 198 · see citing works

Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

Thigpen, T., Brady, M. F., Homesley, H. D., Soper, J. T., & Bell, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.364 · Cited by 191 · see citing works

Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients

Smyth, J. F., Gourley, C., Walker, G. E., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2878 · Cited by 190 · see citing works

Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven

Attard, G., Reid, A. H. M., Olmos, D., & Bono, J. S. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4531 · Cited by 168 · see citing works

Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer

Dixon, J. M., Renshaw, L., Young, O., Murray, J., Macaskill, E. J., McHugh, M., Folkerd, E. J., Cameron, D., A’Hern, R., & Dowsett, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9279 · Cited by 160 · see citing works

The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group

Ma, B. B. Y., Oza, A. M., Eisenhauer, E. A., Stanimir, G., Carey, M. S., Chapman, W. B., Latta, E. K., Sidhu, K., Powers, J., Walsh, W. R., et al. (2004) · International Journal of Gynecological Cancer · doi:10.1111/j.1048-891x.2004.14419.x · Cited by 159 · see citing works

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation

Raso, M. G., Behrens, C., Herynk, M. H., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0033 · Cited by 157 · see citing works

ERβ in breast cancer—Onlooker, passive player, or active protector?

Fox, E. M., Davis, R. J., & Shupnik, M. A. (2008) · Steroids · doi:10.1016/j.steroids.2008.04.006 · Cited by 154 · see citing works

Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial

Schellhammer, P. F., Sharifi, R., Block, N. L., et al. (1997) · Urology · doi:10.1016/s0090-4295(97)00279-3 · Cited by 148 · see citing works

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

Wang, Y., Kreisberg, J. I., & Ghosh, P. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907781662248 · Cited by 137 · see citing works

Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition

Baglietto, L., English, D. R., Hopper, J. L., MacInnis, R. J., Morris, H. A., Tilley, W. D., Krishnan, K., & Giles, G. G. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0069-3 · Cited by 134 · see citing works

Tissue-specific promoters regulate aromatase cytochrome P450 expression

Simpson, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Corbin, C. J., & Mendelson, C. R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90235-o · Cited by 132 · see citing works

Targeting Aromatase and Estrogen Signaling in Human Non‐Small Cell Lung Cancer

Márquez‐Garbán, D. C., Chen, H., Goodglick, L., Fishbein, M. C., & Pietras, R. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04116.x · Cited by 125 · see citing works

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women

Dunbier, A. K., Anderson, H., Ghazoui, Z. F., Folkerd, E. J., A’Hern, R., Crowder, R. J., Hoog, J., Smith, I. E., Osin, P., Nerurkar, A. Y., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9616 · Cited by 120 · see citing works

Heritability of plasma sex hormones and hormone binding globulin in adult male twins

Ring, H. Z., Lessov, C. N., Reed, T., Marcus, R., Holloway, L., Swan, G. E., & Carmelli, D. (2005) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2004-1025 · Cited by 117 · see citing works

Estrogen Regulation and Physiopathologic Significance of Alternative Promoters in Breast Cancer

Dutertre, M., Gratadou, L., Dardenne, É., Germann, S., Samaan, S., Lidereau, R., Driouch, K., de la Grange, P., & Auboeuf, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3988 · Cited by 105 · see citing works

Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy

Simpson, E. R. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.317 · Cited by 102 · see citing works

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status

Lønning, P. E., Helle, H., Duong, N. K., Ekse, D., Aas, T., & Geisler, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.06.005 · Cited by 98 · see citing works

Intratumoral Estrogen Disposition in Breast Cancer

Haynes, B. P., Straume, A. H., Geisler, J., A’Hern, R., Helle, H., Smith, I. E., Lønning, P. E., & Dowsett, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2481 · Cited by 96 · see citing works

Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition

Travis, R. C., Key, T. J., Allen, N. E., Appleby, P. N., Roddam, A., Rinaldi, S., Egevad, L., Gann, P. H., Rohrmann, S., Linseisen, J., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22814 · Cited by 92 · see citing works

The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer

MacNeill, F., Jones, A. L., Jacobs, S., Lønning, P. E., Powles, T., & Dowsett, M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.339 · Cited by 91 · see citing works

Estrogen Receptor β in Prostate Cancer

Signoretti, S., & Loda, M. F. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61666-5 · Cited by 85 · see citing works

The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance

Sikora, M. J., Cordero, K. E., Larios, J. M., Johnson, M. D., Lippman, M. E., & Rae, J. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0080-8 · Cited by 77 · see citing works

Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer

Walker, G. E., MacLeod, K. G., Williams, A. R. W., et al. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.05.009 · Cited by 76 · see citing works

Pregnenolone stimulates LNCaP prostate cancer cell growth via the mutated androgen receptor

Grigoryev, D. N., Long, B. J., Njar, V. C. O., & Brodie, A. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00131-x · Cited by 72 · see citing works

Highly concordant coexpression of aromatase and estrogen receptor β in non–small cell lung cancer

Abe, K., Miki, Y., Ono, K., Mori, M., Kakinuma, H., Kou, Y., Kudo, N., Koguchi, M., Niikawa, H., Suzuki, S., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.07.010 · Cited by 66 · see citing works

Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in Men

Eriksson, A. L., Lorentzon, M., Vandenput, L., Labrie, F., Lindersson, M., Syvänen, A., ORWOLL, E. S., Cummings, S. R., Zmuda, J. M., Ljunggren, Ö., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1283 · Cited by 64 · see citing works

Heritability of reproductive hormones in adult male twins

Kuijper, E. A. M., Lambalk, C. B., Boomsma, D. I., van der Sluis, S., Blankenstein, M. A., de Geus, E. J. C., & Danielle Posthuma, B. (2007) · Human Reproduction · doi:10.1093/humrep/dem145 · Cited by 64 · see citing works

Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer

Nüssler, N. C., Reinbacher, K., Shanny, N., et al. (2008) · Gender Medicine · doi:10.1016/j.genm.2008.07.005 · Cited by 61 · see citing works

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer

Lønning, P. E., Helle, S. I., Johannessen, D. C., et al. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806162 · Cited by 53 · see citing works

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects

Berstein, L. M., Maximov, S., Gershfeld, E. D., Meshkova, I., Gamajunova, V. B., Tsyrlina, E. V., Larionov, A. A., Ковалевский, А. Ю., & Vasilyev, D. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00147-1 · Cited by 52 · see citing works

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

Buzdar, A. U., Coombes, R. C., Goss, P. E., & Winer, E. P. (2007) · Cancer · doi:10.1002/cncr.23193 · Cited by 46 · see citing works

Gene Expression Profiling of Breast Cancer in Relation to Estrogen Receptor Status and Estrogen-Metabolizing Enzymes: Clinical Implications

Kristensen, V. N., Sørlie, T., Geisler, J., Langerød, A., Yoshimura, N., Kåresen, R., Harada, N., Lønning, P. E., & Børresen‐Dale, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.878s.11.2 · Cited by 36 · see citing works

Absence of Relationship Between Steroid Hormone Levels and Prostate Cancer Tumor Grade

Sher, D. J., Mantzoros, C. S., Jacobus, S. J., Regan, M. M., Lee, G. M., & Oh, W. K. (2008) · Urology · doi:10.1016/j.urology.2008.07.068 · Cited by 34 · see citing works

17β-Hydroxysteroid dehydrogenases and cancers

Vihko, P., Härkönen, P. K., Oduwole, O. O., Törn, S., Kurkela, R., Porvari, K., Pulkka, A. E., & ISOMAA, V. V. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00278-9 · Cited by 33 · see citing works

Ovarian ablation as adjuvant therapy for breast cancer

Dees, E. C. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90126-5 · Cited by 32 · see citing works

Aromatase inhibitors and male breast cancer

Arriola, E., Hui, E., Dowsett, M., et al. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0034-3 · Cited by 30 · see citing works

Sex differences in time trends of colorectal cancer in England and Wales: the possible effect of female hormonal factors

Silva, I. D. S., & Swerdlow, A. J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.120 · Cited by 29 · see citing works

Familial Correlations in Postmenopausal Serum Concentrations of Sex Steroid Hormones and Other Mitogens: A Twins and Sisters Study

Stone, J., Folkerd, E. J., Doody, D., Schroen, C., Treloar, S. A., Giles, G. G., Pike, M. C., English, D. R., Southey, M. C., Hopper, J. L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0713 · Cited by 24 · see citing works

LOW-DOSE AMINOGLUTETHIMIDE AND AROMATASE INHIBITION

Dowsett, M., Jeffcoate, S. L., Santner, S. J., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91955-5 · Cited by 19 · see citing works

Childhood cancer among the polynesian population

Ridgway, D., Skeen, J., Mauger, D. C., & Becroft, D. M. O. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2 · Cited by 11 · see citing works

Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy

van Aubel, O. G. J. M., Vries, J. B., Blankenstein, M. A., et al. (1989) · Urological Research · doi:10.1007/bf00262028 · Cited by 6 · see citing works

Sex differences and sex steroids in lung health and disease

Townsend, E. A., Miller, V. M., & Prakash, Y. S. (2012) · Endocrine Reviews · doi:10.1210/er.2010-0031 · Cited by 395 · see citing works

Beyond DNA Repair: Additional Functions of PARP-1 in Cancer

Weaver, A. N., & Yang, E. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00290 · Cited by 246 · see citing works

Denisovan and Neanderthal archaic introgression differentially impacted the genetics of complex traits in modern populations

Koller, D., Wendt, F. R., Pathak, G. A., De Lillo, A., De Angelis, F., Cabrera-Mendoza, B., Tucci, S., & Polimanti, R. (2022) · BMC Biology · doi:10.1186/s12915-022-01449-2 · Cited by 27 · see citing works